Medpace Holdings, Inc. MEDP
618.88
(1.71)
(0.28%)
as of 25 Sep
- Market cap
- $17.3B
- P/E
- 35.6×
Follow MEDP
Growth Flags
show if company had growth for consecutive years
| Older periods | Sep '25 | Dec '25 | Mar '26 | Jun '26 | |
|---|---|---|---|---|---|
|
+8 more TTM periods Free account |
73.71% | 70.23% | 77.25% | 162.15% | |
| 22.57% | 22.13% | 22.87% | 27.09% | ||
ROIC |
3,822.71% | 0.00% | 0.00% | 0.00% | |
Return on Tangible Assets |
(104.74%) | (202.23%) | (663.29%) | (215.54%) | |
Average Days of Receivables |
57.73 | 58.00 | 53.77 | 57.96 | |
Free Cash Flow per Share |
24.05 | 23.64 | 25.00 | 25.08 | |
Free Cash Flow |
676.77 | 681.87 | 711.00 | 706.69 | |
Capital Expenditures |
(34.46) | (31.36) | (28.18) | (45.97) | |
Piotroski F-Score |
6.00 | 6.00 | 7.00 | 7.00 | |
| Other line items | |||||
Cash ROIC |
122.84% | 74.60% | 59.09% | 80.37% | |
Accounts Receivable Turnover |
6.89 | 7.24 | 7.73 | 6.79 | |
Accounts Payable Turnover |
27.22 | 24.13 | 15.72 | 19.04 | |
Inventory Turnover |
0.00 | 0.00 | 0.00 | 0.00 | |
Average Days of Payables |
13.49 | 14.03 | 16.70 | 17.80 | |
Days of Inventory on Hand |
0.00 | 0.00 | 0.00 | 0.00 | |
Tax Rate |
(0.17) | (0.17) | (0.19) | (0.18) | |
Research and Development Expense of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | |
Selling, General and Administrative Expense of Revenue |
8.40% | 7.81% | 7.00% | 6.79% | |
Share Based Compensation of Revenue |
1.49% | 1.37% | 0.85% | 0.76% | |
Interest Coverage |
0.00 | 0.00 | 0.00 | 0.00 | |
Operating CF/Net income |
1.64 | 1.58 | 1.61 | 1.53 | |
Depreciation/Fixed assets |
0.21 | 0.21 | 0.21 | 0.18 | |
Capex/Depreciation |
(1.21) | (1.11) | (1.00) | (1.65) | |
Revenue per Share |
83.82 | 87.72 | 94.16 | 98.75 | |
Operating CF per Share |
25.28 | 24.73 | 25.99 | 26.71 | |
Capex per Share |
(1.22) | (1.09) | (0.99) | (1.63) | |
Capex to Sales |
0.01 | 0.01 | 0.01 | 0.02 | |
Net Profit Margin |
18.36% | 17.83% | 17.19% | 17.67% |
Columns are period end dates